Literature DB >> 24976231

Accuracy of transrectal ultrasonography to evaluate pathologic prostate weight: correlation with various prostate size groups.

Marc Bienz1, Pierre-Alain Hueber1, Naif Al-Hathal1, Michael McCormack1, Naeem Bhojani1, Quoc-Dien Trinh2, Kevin C Zorn3.   

Abstract

OBJECTIVE: To report the accuracy of transrectal ultrasonography (TRUS) to measure prostate size before robotic-assisted radical prostatectomy using the prolate ellipsoid formula and its correlation to the weight of the postoperative prostate specimen, for different prostate size groups.
METHODS: Preoperative prostate size estimated by TRUS and the weight of postoperative prostate specimens were collected from 440 men undergoing robotic-assisted radical prostatectomy. Patients were grouped according to preoperative prostate size: <30, 30-60, 60-80, and ≥80 g. To evaluate accuracy, the mean absolute percentage of error was used. The mean percentage of error was used to indicate whether the estimation of TRUS had a tendency to overestimate or underestimate prostate size. The correlation between both measurements was analyzed for each size group.
RESULTS: Accuracy of TRUS estimation was associated with increased prostate size. TRUS estimation was more accurate for larger prostates. The mean absolute percentage of error of each group was 38.64% (<30 g), 21.33% (30-60 g), 13.23% (60-80 g), and 14.96% (≥80 g). Correlation followed a similar size-dependent trend, with a stronger r coefficient for larger prostates: 0.174 (<30 g), 0.327 (30-60 g), 0.457 (60-80 g), and 0.839 (≥80 g). Interestingly, smaller prostates were underestimated, whereas larger glands (≥80 g) had a tendency to be overestimated by TRUS.
CONCLUSION: This study demonstrates that the accuracy of the prolate ellipsoid formula for TRUS varies according to prostate size. Although this formula is fairly accurate for assessing larger prostates, it shows some limitations for smaller prostates. This must be taken into account when evaluating treatment modalities such as transurethral incision of the prostate and brachytherapy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24976231     DOI: 10.1016/j.urology.2014.02.022

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Let's not forget about TUIP: A highly underutilized, minimally-invasive and durable technique for men with <30 g prostates.

Authors:  Pierre-Alain Hueber; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.

Authors:  Emma H Allott; Ilona Csizmadi; Lauren E Howard; Roberto L Muller; Daniel M Moreira; Gerald L Andriole; Claus G Roehrborn; Stephen J Freedland
Journal:  BJU Int       Date:  2019-09-27       Impact factor: 5.588

3.  Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists.

Authors:  Benjamin C Trumble; Jonathan Stieglitz; Daniel Eid Rodriguez; Edhitt Cortez Linares; Hillard S Kaplan; Michael D Gurven
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-04-28       Impact factor: 6.053

4.  Correlation Analyses of Computed Tomography and Magnetic Resonance Imaging for Calculation of Prostate Volume in Colorectal Cancer Patients with Voiding Problems Who Cannot Have Transrectal Ultrasonography.

Authors:  Sung Han Kim; Boram Park; Whi-An Kwon; Jae Young Joung; Ho Kyung Seo; Jinsoo Chung; Kang Hyun Lee
Journal:  Biomed Res Int       Date:  2019-03-31       Impact factor: 3.411

Review 5.  How Accurately Can Prostate Gland Imaging Measure the Prostate Gland Volume? Results of a Systematic Review.

Authors:  David R H Christie; Christopher F Sharpley
Journal:  Prostate Cancer       Date:  2019-03-03

6.  Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate.

Authors:  Yung-Ting Cheng; Jian-Hua Hong; Yu-Chuan Lu; Yi-Kai Chang; Shih-Chun Hung; Kuo-Kang Feng; Shih-Ping Liu; Po-Ming Chow; Hong-Chiang Chang; Chung-Hsin Chen; Yeong-Shiau Pu
Journal:  Front Oncol       Date:  2022-07-15       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.